Stock Price Forecast

March 15, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Fortress Biotech Inc chart...

About the Company

fortress biotech, inc. is a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products. fortress plans to develop and commercialize products that it acquires both directly as well as indirectly by establishing subsidiary companies, also known as fortress companies. the company will leverage its biopharmaceutical business expertise and drug development capabilities to help the fortress companies achieve their goals. additionally, the company will provide funding and management services to each of the fortress companies and from time to time the company and the fortress companies will seek licensing, partnerships, joint ventures, and/or public and private financings to accelerate and provide additional funding to support their research and development programs.

$80M

Total Revenue

38

Employees

$24M

Market Capitalization

-1.02

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $FBIO News

Fortress Biotech, Inc. 9.375% CUM RED PER PREF SER A USD25.00 goes ex dividend tomorrow

1mon ago, source: Hosted on MSN

Fortress Biotech, Inc. 9.375% CUM RED PER PREF SER A USD25.00 (NASDAQ:FBIOP) had declared $0.195/share monthly dividend, Payable Feb. 29; for shareholders of record Feb. 15; ex-div Feb. 14.

Fortress Biotech and Cyprium Therapeutics Announce $4.1 Million Grant from NINDS to Further Development of AAV-ATP7A Gene Therapy for Menkes Disease

14d ago, source:

Encouraging preclinical studies demonstrate potential to combine AAV-ATP7A gene therapy with CUTX-101, which could be the ...

Fortress Biotech Inc. 9.375% Cum. Pfd. Series A

1mon ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Fortress Biotech to Participate in 36th Annual ROTH Conference

6d ago, source:

MIAMI, March 12, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on efficiently acquiring, developing and commercializing or monetizing promising ...

Fortress Biotech Inc FBIO

5d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

FBIOP Fortress Biotech, Inc. 9.375% CUM RED PER PREF SER A USD25.00

3d ago, source: Seeking Alpha

**NM signifies a non meaningful value. A dash signifies the data is not available.

Fortress Biotech and Cyprium Therapeutics Announce $4.1 Million Grant from NINDS to Further Development of AAV-ATP7A Gene Therapy for Menkes Disease

14d ago, source: Stockhouse

Cyprium was founded by Fortress Biotech, Inc. (Nasdaq: FBIO) and is based in Miami. For more information, visit www.cypriumtx.com. About Fortress Biotech Fortress Biotech, Inc.

Fortress Biotech Inc FBIO

5d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

FBIOP Fortress Biotech, Inc. 9.375% CUM RED PER PREF SER A USD25.00

1mon ago, source: Seeking Alpha

**NM signifies a non meaningful value. A dash signifies the data is not available.

Fortress Biotech Inc

20d ago, source: U.S. News & World Report

Not all exchange-traded funds are created equal. These five-star funds are some of the cream of the ETF crop. Investing can help you reach the $1 million mark if you start early, stay in the ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...